Synthesis, characterization and in vitro anti-neoplastic activity of gypsogenin derivatives

Here, as part of our ongoing studies, we report the isolation of the known saponin gypsogenin (L1) and the synthesis and potential anticancer activity of new gypsogenin ligands (gypsogenin thiosemicarbazone (L2) and gypsogenin thiosemicarbazone glyoxime (L3H2). In addition, we determined the antipro...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Bioorganic chemistry 2014-04, Vol.53, p.15-23
Hauptverfasser: Emirdağ-Öztürk, Safiye, Babahan, İlknur, Özmen, Ali
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Here, as part of our ongoing studies, we report the isolation of the known saponin gypsogenin (L1) and the synthesis and potential anticancer activity of new gypsogenin ligands (gypsogenin thiosemicarbazone (L2) and gypsogenin thiosemicarbazone glyoxime (L3H2). In addition, we determined the antiproliferative activities of the novel Cu(II) and Co(II) complexes of L3H2 for the first time using human promyelocytic leukemia (HL 60) cells. The Cu(II) complex of L3H2 was determined to have the strongest antiproliferative activity, with an IpC50 value of 5μM. Cell death was distinguished by HO/PI double staining. The Co(II) complex of L3H2 has shown approximately %50 apoptotic effect at 10μM concentration. Paclitaxel has been used as positive control. [Display omitted] •Preparation of novel ligands.•Preparation of novel complexes.•Characterization of ligands and complexes.•Using 1H NMR, 13C NMR, MS and infrared spectroscopy.•Antiproliferative activity. Gypsogenin (L1; 3-hydroxy-23-oxoolean-12-en-28-oic acid), a natural saponin, was isolated from the boiling water extract of Gypsophila arrostii roots. In addition, the derivatives gypsogenin thiosemicarbazone (L2; 23-[(aminocarbonothioyl)hydrazono]-3-hydroxolean-12-en-28-oic acid) and gypsogenin thiosemicarbazone glyoxime (L3H2; (3β)-3-hydroxy-23-[({[(1Z,2E)-N-hydroxy-2-(hydroxyimino)ethanimidoyl]amino}carbonothioyl)hydrazono] olean-12-en-28-oic acid) as well as the Cu(II) and Co(II) complexes of L3H2 were prepared. The structures were established on NMR analysis (1H, 13C NMR, HMBC, HMQC, and NOESY), FT-IR and completed by analysis of LC/MS. Furthermore, the antiproliferative effects of the Co(II) and Cu(II) complexes of the gypsogenin derivatives were assayed in human promyelocytic leukemia (HL 60) cells. These complexes were found to be potent anticancer agents with concentrations that inhibited 50% of proliferation (IpC50) between 5μM and 40μM. Cell death was distinguished by HO/PI double staining. The Co(II) complex of L3H2 has shown approximately %50 apoptotic effect at 10μM concentration. Paclitaxel has been used as positive control.
ISSN:0045-2068
1090-2120
DOI:10.1016/j.bioorg.2013.12.001